Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Spay and Neuter Market, by Region, 2020-2030 (USD Billion)
1.2.2. Spay and Neuter Market, by Species, 2020-2030 (USD Billion)
1.2.3. Spay and Neuter Market, by Provider, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Spay and Neuter Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Spay and Neuter Market Dynamics
3.1. Spay and Neuter Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing rates of pet adoption
3.1.1.2. Growing demand for spay/neutering procedures
3.1.2. Market Challenges
3.1.2.1. Misinformation surrounding risks associated with the surgeries
3.1.2.2. Resistance from pet owners to opt for spaying or neutering procedures
3.1.3. Market Opportunities
3.1.3.1. Increasing awareness among pet owners
3.1.3.2. Rising favorable initiatives from public and private entities to control pet overpopulation
Chapter 4. Global Spay and Neuter Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Spay and Neuter Market, by Species
5.1. Market Snapshot
5.2. Global Spay and Neuter Market by Species, Performance – Potential Analysis
5.3. Global Spay and Neuter Market Estimates & Forecasts by Species 2020-2030 (USD Billion)
5.4. Spay and Neuter Market, Sub Segment Analysis
5.4.1. Dogs
5.4.2. Cats
5.4.3. Others
Chapter 6. Global Spay and Neuter Market, by Provider
6.1. Market Snapshot
6.2. Global Spay and Neuter Market by Provider, Performance – Potential Analysis
6.3. Global Spay and Neuter Market Estimates & Forecasts by Provider 2020-2030 (USD Billion)
6.4. Spay and Neuter Market, Sub Segment Analysis
6.4.1. Veterinary Hospitals
6.4.2. Veterinary Clinics
Chapter 7. Global Spay and Neuter Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Spay and Neuter Market, Regional Market Snapshot
7.4. North America Spay and Neuter Market
7.4.1. U.S. Spay and Neuter Market
7.4.1.1. Species breakdown estimates & forecasts, 2020-2030
7.4.1.2. Provider breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Spay and Neuter Market
7.5. Europe Spay and Neuter Market Snapshot
7.5.1. U.K. Spay and Neuter Market
7.5.2. Germany Spay and Neuter Market
7.5.3. France Spay and Neuter Market
7.5.4. Spain Spay and Neuter Market
7.5.5. Italy Spay and Neuter Market
7.5.6. Rest of Europe Spay and Neuter Market
7.6. Asia-Pacific Spay and Neuter Market Snapshot
7.6.1. China Spay and Neuter Market
7.6.2. India Spay and Neuter Market
7.6.3. Japan Spay and Neuter Market
7.6.4. Australia Spay and Neuter Market
7.6.5. South Korea Spay and Neuter Market
7.6.6. Rest of Asia Pacific Spay and Neuter Market
7.7. Latin America Spay and Neuter Market Snapshot
7.7.1. Brazil Spay and Neuter Market
7.7.2. Mexico Spay and Neuter Market
7.8. Middle East & Africa Spay and Neuter Market
7.8.1. Saudi Arabia Spay and Neuter Market
7.8.2. South Africa Spay and Neuter Market
7.8.3. Rest of Middle East & Africa Spay and Neuter Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Boehringer Ingelheim Animal Health
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Merck Animal Health
8.3.3. Zoetis Inc.
8.3.4. Bayer AG
8.3.5. IDEXX Laboratories, Inc.
8.3.6. Virbac
8.3.7. VCA Inc.
8.3.8. Medtronic plc
8.3.9. Ethicon US, LLC
8.3.10. Covetrus, Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/